Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Breast Neoplasms × Epirubicin × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 169 Observational 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Pancreatic Neoplasms 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1 Breast Cancer Organoids 1 Biliary Tract Neoplasms 1

Interventions

Surveys and Questionnaires 62 Blood Specimen Collection 47 palbociclib 30 Trastuzumab 27 Immunohistochemistry 23 Letrozole 21 Drug Therapy 21 Radiotherapy 20 Anastrozole 20 Gene Expression Profiling 18 Tamoxifen 17 Biopsy 16 Amplified Fragment Length Polymorphism Analysis 16 ribociclib 15 exemestane 15 Interviews as Topic 15 Fulvestrant 15 Mastectomy, Segmental 14 Psychiatric Rehabilitation 12 Observation 12 Capecitabine 12 Polymerase Chain Reaction 11 Mastectomy 11 Magnetic Resonance Spectroscopy 11 Reverse Transcriptase Polymerase Chain Reaction 10 Neoadjuvant Therapy 10 Microarray Analysis 10 High-Energy Shock Waves 10 trastuzumab deruxtecan 9 abemaciclib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05131893 2021-11-23

Neoadjuvant Treatment of Breast Cancer

National Institute of Oncology, Hungary

Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡